Maarten De Chateau
chairman
management
Oxthera
Sweden
Biography
Co-founder and CEO of Cormorant Pharmaceuticals developing an immuno-oncology mAb, acquired by Bristol-Myers Squibb in 2016. Prior to that, Medical Director at Swedish Orphan Biovitrum, with medical/clinical development responsibility for two marketed products in the rare disease space. Worked in clinical development at Sanofi and also as a financial analyst at two investment banks for five years.
Research Interest
medical/clinical development
